Signal Peptide Website
Search my Protein
Advanced Search
Database Search
References
Hints
Links
Imprint
Signal Peptide Database - Mammalia
Entry Details
ID
332
Source Database
UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number
P54803 (Created: 1996-10-01 Updated: 2009-01-20)
UniProtKB/Swiss-Prot Entry Name
GALC_HUMAN
Protein Name
Galactocerebrosidase
Gene
GALC
Organism Scientific
Homo sapiens
Organism Common
Human
Lineage
Eukaryota
Metazoa
Chordata
Craniata
Vertebrata
Euteleostomi
Mammalia
Eutheria
Euarchontoglires
Primates
Haplorrhini
Catarrhini
Hominidae
Homo
Protein Length [aa]
669
Protein Mass [Da]
75147
Features
Type
Description
Status
Start
End
signal peptide
1
26
chain
Galactocerebrosidase
27
669
glycosylation site
N-linked (GlcNAc...)
potential
127
127
glycosylation site
N-linked (GlcNAc...)
potential
363
363
glycosylation site
N-linked (GlcNAc...)
potential
387
387
glycosylation site
N-linked (GlcNAc...)
potential
540
540
glycosylation site
N-linked (GlcNAc...)
potential
543
543
glycosylation site
N-linked (GlcNAc...)
potential
586
586
sequence variant
(in GLD)
0
0
sequence variant
(in GLD; infantile)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in GLD; infantile; significant reduction of activity)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in GLD; bilateral cherry red spots)
0
0
sequence variant
(in GLD; infantile; significant reduction of activity)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in GLD; infantile; significant reduction of activity)
0
0
sequence variant
(in GLD; Arab patients)
0
0
sequence variant
(in GLD; loss of activity)
0
0
sequence variant
(in GLD; infantile; significant reduction of activity)
0
0
sequence variant
(in GLD; adult)
0
0
sequence variant
(in significant reduction of activity when associated with T-546; dbSNP:rs421262)
0
0
sequence variant
(in GLD; adult)
0
0
sequence variant
(in GLD; infantile; Druze patients)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in GLD; belgian patient)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in common polymorphism; dbSNP:rs398607)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in dbSNP:rs1805079)
0
0
sequence variant
(in GLD; adult)
0
0
sequence variant
(in GLD; adult)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in GLD; adult; reduction of activity; when associated with V-289)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in GLD; infantile; significant reduction of activity)
0
0
sequence variant
(in GLD; infantile; significant reduction of activity)
0
0
sequence variant
(in dbSNP:rs1805078)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in GLD; infantile)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in GLD; infantile; significant reduction of activity)
0
0
sequence variant
(in GLD)
0
0
sequence variant
(in GLD; late infantile)
0
0
sequence variant
0
0
splice variant
(in isoform 2)
0
0
splice variant
(in isoform 2)
392
669
SP Length
26
----+----1----+----2----+----3----+----4----+----5
Signal Peptide
MTAAAGSAGRAAVPLLLCALLAPGGA
Sequence
MTAAAGSAGRAAVPLLLCALLAPGGA
YVLDDSDGLGREFDGIGAVSGGGA
TSRLLVNYPEPYRSQILDYLFKPNFGASLHILKVEIGGDGQTTDGTEPSH
MHYALDENYFRGYEWWLMKEAKKRNP
N
ITLIGLPWSFPGWLGKGFDWPYV
NLQLTAYYVVTWIVGAKRYHDLDIDYIGIWNERSYNANYIKILRKMLNYQ
GLQRVKIIASDNLWESISASMLLDAELFKVVDVIGAHYPGTHSAKDAKLT
GKKLWSSEDFSTLNSDMGAGCWGRILNQNYINGYMTSTIAWNLVASYYEQ
LPYGRCGLMTAQEPWSGHYVVESPVWVSAHTTQFTQPGWYYLKTVGHLEK
GGSYVALTDGLG
N
LTIIIETMSHKHSKCIRPFLPYF
N
VSQQ
FATFVLKGS
FSEIPELQVWYTKLGKTSERFLFKQLDSLWLLDSDGSFTLSLHEDELFTL
TTLTTGRKGSYPLPPKSQPFPSTYKDDFNVDYPFFSEAPNFADQTGVFEY
FTNIEDPGEHHFTLRQVLNQRPITWAADASNTISIIGDYNWTNLTIKCDV
YIETPDTGGVFIAGRVNKGGILIRSARGIFFWIFANGSYRVTGDLAGWII
YALGRVEVTAKKWYTLTLTIKGHFASGMLNDKSLWTDIPVNFPKNGWAAI
GTHSFEFAQFDNFLVEATR
Original
MTAAAGSAGRAAVPLLLCALLAPGGAYVLDDSDGLGREFDGIGAVSGGGA
TSRLLVNYPEPYRSQILDYLFKPNFGASLHILKVEIGGDGQTTDGTEPSH
MHYALDENYFRGYEWWLMKEAKKRNPNITLIGLPWSFPGWLGKGFDWPYV
NLQLTAYYVVTWIVGAKRYHDLDIDYIGIWNERSYNANYIKILRKMLNYQ
GLQRVKIIASDNLWESISASMLLDAELFKVVDVIGAHYPGTHSAKDAKLT
GKKLWSSEDFSTLNSDMGAGCWGRILNQNYINGYMTSTIAWNLVASYYEQ
LPYGRCGLMTAQEPWSGHYVVESPVWVSAHTTQFTQPGWYYLKTVGHLEK
GGSYVALTDGLGNLTIIIETMSHKHSKCIRPFLPYFNVSQQFATFVLKGS
FSEIPELQVWYTKLGKTSERFLFKQLDSLWLLDSDGSFTLSLHEDELFTL
TTLTTGRKGSYPLPPKSQPFPSTYKDDFNVDYPFFSEAPNFADQTGVFEY
FTNIEDPGEHHFTLRQVLNQRPITWAADASNTISIIGDYNWTNLTIKCDV
YIETPDTGGVFIAGRVNKGGILIRSARGIFFWIFANGSYRVTGDLAGWII
YALGRVEVTAKKWYTLTLTIKGHFASGMLNDKSLWTDIPVNFPKNGWAAI
GTHSFEFAQFDNFLVEATR
----+----1----+----2----+----3----+----4----+----5
Hydropathies
Home
Imprint
© 2007-2017
Dr. Katja Kapp
, Kassel &
thpr.net e. K.
, Dresden, Germany, last update 2010-06-11